Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL DEVICE NEWS IN BRIEF
July 7, 2008
- Bayer Yakuhin to Achieve \200 Bil. Sales in 5 Years
July 7, 2008
- Physician-led Study of Talc to Begin Soon
July 7, 2008
- Daiichi Sankyo to Work Out Collaboration Plans Country by Country: Mr Shoda
July 7, 2008
- Sawai Aims at Achieving \100 Bil. Sales before Any Other Generic Company in Japan
July 7, 2008
- Otsuka Pharm. to Be Reorganized under New Holding Company
July 7, 2008
- Blopress Best-Selling Ethical Drug 4 Years in a Row
July 7, 2008
- Ethical Drugs Market Up to \8,136.3 Bil. in FY2007: IMS Japan
July 7, 2008
- RNAi Drugs Development Race Heats Up with Entry of Kyowa Hakko
June 30, 2008
- Kyowa Hakko Licenses RNAi Drug for RSV Infection from Alnylam
June 30, 2008
- Annual Meeting of Japanese Society of Chemotherapy
June 30, 2008
- Okayama Univ. to Lead Gene Therapy Research for Prostate Cancer in Asians
June 30, 2008
- R&D NEWS IN BRIEF
June 30, 2008
- Abbott Vascular Applies for XIENCE V
June 30, 2008
- Abbott Japan to Increase Pharma Group Sales to US$1 Bil. within 2 Years
June 30, 2008
- Terumo Acquires Clinical Supply from Eisai
June 30, 2008
- SELF-MEDICATION NEWS IN BRIEF
June 30, 2008
- Taiyo Leads Industry by Production Capacity and Prices: Mr Aratani
June 30, 2008
- NEW PRODUCTS
June 30, 2008
- 29.4% of Prescriptions Substituted Resulting in Savings of \420 Mil. in May: Nihon Chouzai
June 30, 2008
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…